TY - JOUR
T1 - A new hemostasis valve for neuroendovascular procedures
AU - Namba, K.
AU - Song, J. K.
AU - Niimi, Y.
AU - Heran, N. S.
AU - Berenstein, A.
PY - 2007/3
Y1 - 2007/3
N2 - A hemostasis valve is routinely used in neuroendovascular procedures to decrease the risk of thromboembolism1,2. Recently, a new hemostasis valve that is designed to minimize blood loss has been introduced. We report our initial experience in using this new hemostasis valve. In neuroendovascular procedures, a hemostasis valve is commonly used for continuous irrigation of guide and microcatheters to decrease the risk of thromboembolism1,2,3. A conventional hemostasis valve has a rotating seal at the end, which is turned open or closed each time a wire or microcatheter/guidewire is introduced or extracted. Often this results in significant back bleeding. When a rotating seal is adjusted suboptimally during a wire or microcatheter manipulation, leakage of pressurized saline from the end of a hemostasis valve results in stagnation of blood within a guiding catheter, which becomes a potential source of emboli during a procedure. The Guardian Haemostasis Valve (Zerusa Limited, Galway, Ireland) is a new hemostasis valve that is designed to minimize blood loss during interventional procedures by minimizing the opening time of the valve during wire or microcatheter insertion. A continuous sealing mechanism during wire or microcatheter positioning minimizes blood loss and stagnation of blood within the guide catheter. We report our initial experience with the Guardian hemostasis valve.
AB - A hemostasis valve is routinely used in neuroendovascular procedures to decrease the risk of thromboembolism1,2. Recently, a new hemostasis valve that is designed to minimize blood loss has been introduced. We report our initial experience in using this new hemostasis valve. In neuroendovascular procedures, a hemostasis valve is commonly used for continuous irrigation of guide and microcatheters to decrease the risk of thromboembolism1,2,3. A conventional hemostasis valve has a rotating seal at the end, which is turned open or closed each time a wire or microcatheter/guidewire is introduced or extracted. Often this results in significant back bleeding. When a rotating seal is adjusted suboptimally during a wire or microcatheter manipulation, leakage of pressurized saline from the end of a hemostasis valve results in stagnation of blood within a guiding catheter, which becomes a potential source of emboli during a procedure. The Guardian Haemostasis Valve (Zerusa Limited, Galway, Ireland) is a new hemostasis valve that is designed to minimize blood loss during interventional procedures by minimizing the opening time of the valve during wire or microcatheter insertion. A continuous sealing mechanism during wire or microcatheter positioning minimizes blood loss and stagnation of blood within the guide catheter. We report our initial experience with the Guardian hemostasis valve.
KW - Angiographic device
KW - Angiography
KW - Hemostatic valve
UR - http://www.scopus.com/inward/record.url?scp=34250222734&partnerID=8YFLogxK
U2 - 10.1177/159101990701300106
DO - 10.1177/159101990701300106
M3 - Article
AN - SCOPUS:34250222734
VL - 13
SP - 51
EP - 53
JO - Interventional Neuroradiology
JF - Interventional Neuroradiology
SN - 1123-9344
IS - 1
ER -